As the new year sets in with hopeful resolutions, Illinois Attorney General Kwame Raoul issued a reminder to residents seeking a fresh start through weight loss: watch out for misleading sellers of GLP-1 drugs. According to a consumer alert, the Attorney General's office is highlighting a trend of unapproved versions of popular medications like Ozempic, Wegovy, Mounjaro, and Zepbound being marketed by some med spas and online sellers, potentially jeopardizing public health—a warning that resonates beyond the Illinois borders as the demand for weight loss solutions skyrockets with New Year's resolutions.
These medications, touted for their weight loss benefits, can lead consumers down dangerous paths when purchased from less-than-reputable sources. Compounded drugs—those not approved by the FDA but concocted on-site for specific patient needs when shortages arise—may pose significant health risks despite their availability in times of scarcity. The FDA allows large pharmacies under special circumstances to whip up versions of sought-after medications using active ingredients to satiate public needs, albeit without the standard review for safety or effectiveness, as was highlighted in the Attorney General's announcement. Raoul's office has taken action, dispatching cease and desist letters to five med spas engaged in spreading potentially dangerous misinformation.
These misleading sales practices take various forms, from selling medications without a prescription to offering concoctions and formats—like drops and skin patches— that haven't been evaluated for safety. "With scammers and bad actors marketing untested products using brand names, it is critical that consumers obtain prescriptions for GLP-1 medications from their health care providers and fill them at a licensed pharmacy," Raoul underscored in the consumer alert. The FDA too, has stepped in, trying to halt the flow of these unauthorized versions of GLP-1 products into the market.
For those considering GLP-1 medicines, Attorney General Raoul laid out critical questions to ponder: Is the provider legitimate, does the method of administration align with regulatory standards, and are the side effects and risks transparently communicated? His advice is to vet the product carefully, and if doubts exist, steer clear to avoid plausible serious health repercussions associated with these shady supplements. Validated GLP-1 therapies should have transparent origins, straightforward usage instructions, and clear health warnings. Any deviation from this might be a loud enough alarm bell to send consumers sprinting in the opposite direction.
Illinois residents and all consumers are advised to gravitate toward trusted sources for their prescriptions and to utilize state-licensed pharmacies for their medications. For those unsure about the safety of online pharmacies, the FDA's webpage provides further guidance for securely obtaining prescription medicines.
